Drugnet Europe 81


Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the agency's activities to a broad readership. In this issue: EU drug markets report highlights; new EU drug strategy endorsed; upcoming risk assessment of 5-IT; European summer school on illicit drugs; call for EU-wide ban on 4-MA; Third international forum on new drugs.

Download as PDF